Medi Caps Intrinsic Value
MEDICAPQ Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹78.60 | ₹70.74 - ₹86.46 | +150.0% | Book Value/Share: ₹93.08, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹24.62 | ₹22.16 - ₹27.08 | -21.7% | Revenue/Share: ₹12.31, P/S: 2.0x |
| Simple DCF (5Y) | dcf | ₹35.71 | ₹28.57 - ₹42.85 | +13.6% | CF Growth: 5.0%, Discount: 15% |
Want to compare with current market value? Check MEDICAPQ share price latest .
Valuation Comparison Chart
MEDICAPQ Intrinsic Value Analysis
What is the intrinsic value of MEDICAPQ?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Medi Caps (MEDICAPQ) is ₹35.71 (median value). With the current market price of ₹31.44, this represents a +13.6% variance from our estimated fair value.
The valuation range spans from ₹24.62 to ₹78.60, indicating ₹24.62 - ₹78.60.
Is MEDICAPQ undervalued or overvalued?
Based on our multi-method analysis, Medi Caps (MEDICAPQ) appears to be trading below median value by approximately 13.6%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 53.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.03 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | -6.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -145.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.13x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Medi Caps
Additional stock information and data for MEDICAPQ
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹5 Cr | ₹3 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹7 Cr | ₹3 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹-6 Cr | ₹-8 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹7 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹15 Cr | ₹10 Cr | Positive Free Cash Flow | 8/10 |